121 related articles for article (PubMed ID: 15496272)
1. Erythropoietic agents in chemotherapy-induced anemia: a review of recent therapeutic progress, issues, and concerns.
Boccia RV
Curr Hematol Rep; 2004 Nov; 3(6):397-405. PubMed ID: 15496272
[TBL] [Abstract][Full Text] [Related]
2. Darbepoetin alfa for the treatment of cancer-related anemia: an update.
Pirker R
Expert Rev Anticancer Ther; 2004 Oct; 4(5):735-44. PubMed ID: 15485310
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of darbepoetin alfa versus epoetin alfa for the treatment of chemotherapy induced anemia in patients with gynecologic malignancies.
Case AS; Rocconi RP; Kilgore LC; Barnes MN
Gynecol Oncol; 2006 Jun; 101(3):499-502. PubMed ID: 16406064
[TBL] [Abstract][Full Text] [Related]
4. Phase III clinical trials with darbepoetin: implications for clinicians.
Glaspy J
Best Pract Res Clin Haematol; 2005; 18(3):407-16. PubMed ID: 15792914
[TBL] [Abstract][Full Text] [Related]
5. Darbepoetin alfa in the treatment of anemia in cancer patients undergoing chemotherapy.
Wauters I; Vansteenkiste J
Expert Rev Anticancer Ther; 2012 Nov; 12(11):1383-90. PubMed ID: 23113603
[TBL] [Abstract][Full Text] [Related]
6. Darbepoetin alfa for chemotherapy-induced anemia: evolution to extended dosing intervals.
Vansteenkiste J; Wauters I
Expert Rev Anticancer Ther; 2007 Oct; 7(10):1347-55. PubMed ID: 17944560
[TBL] [Abstract][Full Text] [Related]
7. Retrospective observational study of patients with chemotherapy-related anemia receiving erythropoietic agents.
Mark TL; McKenzie RS; Fastenau J; Piech CT
Curr Med Res Opin; 2005 Sep; 21(9):1347-54. PubMed ID: 16197652
[TBL] [Abstract][Full Text] [Related]
8. Are there clinical benefits with early erythropoietic intervention for chemotherapy-induced anemia? A systematic review.
Lyman GH; Glaspy J
Cancer; 2006 Jan; 106(1):223-33. PubMed ID: 16331597
[TBL] [Abstract][Full Text] [Related]
9. Epoetin alfa versus darbepoetin alfa in chemotherapy-related anemia.
Cersosimo RJ; Jacobson DR
Ann Pharmacother; 2006 Jan; 40(1):58-65; quiz 169-70. PubMed ID: 16332942
[TBL] [Abstract][Full Text] [Related]
10. Darbepoetin alpha coming of age.
Pedrazzoli P; Cinieri S; Lorusso V; Gamucci T; Secondino S; Silvestris N
Anticancer Res; 2007; 27(6C):4419-24. PubMed ID: 18214054
[TBL] [Abstract][Full Text] [Related]
11. Comparative studies on erythropoietic agents.
Straus D
J Natl Compr Canc Netw; 2005 Nov; 3 Suppl 1():S46-9. PubMed ID: 16280113
[No Abstract] [Full Text] [Related]
12. Evaluating erythropoietic agents for the treatment of anaemia in the oncology setting.
Gascón P
Eur J Cancer; 2005 Nov; 41(17):2601-12. PubMed ID: 16230006
[TBL] [Abstract][Full Text] [Related]
13. Management of cancer-related anemia with erythropoietic agents: doubts, certainties, and concerns.
Stasi R; Amadori S; Littlewood TJ; Terzoli E; Newland AC; Provan D
Oncologist; 2005 Aug; 10(7):539-54. PubMed ID: 16079321
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic use of erythropoietin in dermatooncology.
Satzger I; Schenck F; Thol F; Ganser A; Kapp A; Gutzmer R
J Dtsch Dermatol Ges; 2007 Apr; 5(4):280-5. PubMed ID: 17376091
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietic therapy for the treatment of anemia in patients with cancer: a valuable clinical and economic option.
Cornes P; Coiffier B; Zambrowski JJ
Curr Med Res Opin; 2007 Feb; 23(2):357-68. PubMed ID: 17288690
[TBL] [Abstract][Full Text] [Related]
16. Darbepoetin alfa: potential role in managing anemia in cancer patients.
Pirker R; Smith R
Expert Rev Anticancer Ther; 2002 Aug; 2(4):377-84. PubMed ID: 12647980
[TBL] [Abstract][Full Text] [Related]
17. Targeting anemia in patients with lung cancer.
Crawford J; Kosmidis PA; Hirsch FR; Langer CJ
J Thorac Oncol; 2006 Sep; 1(7):716-25. PubMed ID: 17409943
[TBL] [Abstract][Full Text] [Related]
18. Erythropoietin for oncology supportive care.
McKinney M; Arcasoy MO
Exp Cell Res; 2011 May; 317(9):1246-54. PubMed ID: 21396935
[TBL] [Abstract][Full Text] [Related]
19. Randomized comparison of every-2-week darbepoetin alfa and weekly epoetin alfa for the treatment of chemotherapy-induced anemia: the 20030125 Study Group Trial.
; Glaspy J; Vadhan-Raj S; Patel R; Bosserman L; Hu E; Lloyd RE; Boccia RV; Tomita D; Rossi G
J Clin Oncol; 2006 May; 24(15):2290-7. PubMed ID: 16710026
[TBL] [Abstract][Full Text] [Related]
20. Treatment of anemia with darbepoetin alfa in the radiation oncology setting.
Finney D; Allison RR
J Support Oncol; 2005; 3(6 Suppl 4):6-7. PubMed ID: 16355547
[No Abstract] [Full Text] [Related]
[Next] [New Search]